Tuberculosis
Isoniazid Prophylaxis Decreases Risk of Recurrent TB in HIV-1 Patients
Published in AIDS Weekly, December 4th, 2000
Researchers also determined that prophylactic isoniazid treatment of HIV-1 patients who have had TB reduces the chance that they will experience recurrence of the disease.
The study comprised 233 adult patients who had successfully completed six months of rifampicin treatment for active pulmonary tuberculosis. Of these, 142 were positive for HIV-1 and were randomized to receive either post-treatment isoniazid prophylaxis (n=68) for one year or placebo (n=74). The remaining 91 patients were not...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2000-12-04)
More Articles from AIDS Weekly
- AIDS Therapies
First Randomized, Control Study of Scheduled Intermittent HAART Conducted in Monkeys - Pathology
T-Cell's Internal Housekeeping Service Plays Role in HIV Infection - Clinical Trials
Recruiting At-Risk Women to HIV Vaccine Trials Isn't Easy - Disease Progression
Human Thrombospondin-1 Modulates Extracellular Tat Availability, Activity - Ehrlichiosis
Tick-Vectored Disease Can Be Deadly in HIV Patients - Epidemiology
Pneumocystis carinii Pneumonia Cases Cluster in Specific Zip Code Areas in U.S. - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
